logo
搜索
菜单

efficacy的搜索结果

当前1/3页
排序: 最近更新
Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung 10.3791/3857-v
Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood 10.3791/3852-v
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
15.4: Actuarial Approach 01:20 min
15.4: Actuarial Approach
15.3: Survival Curves 01:18 min
15.3: Survival Curves
16.12: Oral Drug Delivery Systems: Continuous-Release Systems 01:26 min
16.12: Oral Drug Delivery Systems: Continuous-Release Systems
16.9: Modified-Release Drug Delivery Systems: Site-Targeted 01:24 min
16.9: Modified-Release Drug Delivery Systems: Site-Targeted
16.6: Modified-Release Drug Delivery Systems: Classification 01:23 min
16.6: Modified-Release Drug Delivery Systems: Classification
15.14: Pharmacodynamic Models: Direct Effect Model and Indirect Response Model 01:29 min
15.14: Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
15.1: Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect 01:26 min
15.1: Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
14.9: Pharmacogenomics: Identification of New Drug Targets 01:29 min
14.9: Pharmacogenomics: Identification of New Drug Targets
12.17: Pharmacokinetics: Drug–Drug Interactions 01:25 min
12.17: Pharmacokinetics: Drug–Drug Interactions
11.3: Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence 01:19 min
11.3: Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
9.8: Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems 01:22 min
9.8: Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
9.7: Measurement of Bioavailability: Pharmacodynamic Methods 01:20 min
9.7: Measurement of Bioavailability: Pharmacodynamic Methods
9.6: Measurement of Bioavailability: Pharmacokinetic Methods 01:30 min
9.6: Measurement of Bioavailability: Pharmacokinetic Methods
9.5: Bioavailability Study Design: Healthy Subjects Versus Patients 01:15 min
9.5: Bioavailability Study Design: Healthy Subjects Versus Patients
The Mouse Forced Swim Test 10.3791/3638-v 06:19 min
The Mouse Forced Swim Test
Stem Cell Transplantation in an in vitro Simulated Ischemia/Reperfusion Model 10.3791/3575-v 09:15 min
Stem Cell Transplantation in an in vitro Simulated Ischemia/Reperfusion Model
8.7: Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model 01:13 min
8.7: Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model
7.28: Noncompartmental Analysis: Mean Transit, Absorption and Dissolution Time 01:02 min
7.28: Noncompartmental Analysis: Mean Transit, Absorption and Dissolution Time
返回顶部